Stimunity is a startup company directed by Sylvain Carlioz, CEO, and located in Paris. The company exploits an exclusive license on patents from Institut Curie, INSERM and Oxford University on a biological therapeutic drug to activate the immunomodulatory STING pathway. Nicolas Manel (PI) heads the innate immunity lab at Institut Curie.Institut Curie is a leading international cancer and research center located in the center of Paris. Institut Curie hosts 1000 researchers in 14 departments, and provides access to cutting-edge core facilities, in a highly international and collaborative environment. His lab at Institut Curie is interested in uncovering the basic principles that operate at the intersection between innate immunity and viral replication and develops application of this research in collaboration with Stimunity.